Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.67 AUD 3.08% Market Closed
Market Cap: 231.1m AUD
Have any thoughts about
Aroa Biosurgery Ltd?
Write Note

Aroa Biosurgery Ltd
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aroa Biosurgery Ltd
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Aroa Biosurgery Ltd
ASX:ARX
Net Issuance of Common Stock
NZ$111k
CAGR 3-Years
-85%
CAGR 5-Years
-58%
CAGR 10-Years
N/A
Pacific Edge Ltd
NZX:PEB
Net Issuance of Common Stock
NZ$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Aroa Biosurgery Ltd
Glance View

Market Cap
230.6m AUD
Industry
Biotechnology

Aroa Biosurgery Ltd. engages in the development of products for wound care and soft tissue regeneration. The firm is engaged in commercializing regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. The company designs and manufactures medical products which enable surgeons and clinicians to repair serious tissue injuries. The Company’s solutions include Endoform platform, Wound Care Portfolio and Reinforced Bioscaffolds. The Endoform platform is a building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing. Its wound care products comprise extracellular matrix to manage acute and chronic wounds. The Reinforced Bioscaffolds combine the biologics and synthetics to address the surgical ventral hernia repair solutions.

ARX Intrinsic Value
1.09 AUD
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Aroa Biosurgery Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
111k NZD

Based on the financial report for Mar 31, 2024, Aroa Biosurgery Ltd's Net Issuance of Common Stock amounts to 111k NZD.

What is Aroa Biosurgery Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-58%

Over the last year, the Net Issuance of Common Stock growth was -79%. The average annual Net Issuance of Common Stock growth rates for Aroa Biosurgery Ltd have been -85% over the past three years , -58% over the past five years .

Back to Top